Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients
Moritz Glaser(University of Cologne), Matthias Scheffler(TH Köln - University of Applied Sciences)
Cited by 2
Related Papers
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
|Cancer Discovery|2023|181
Fully Automated <scp>MR</scp> Detection and Segmentation of Brain Metastases in Non‐small Cell Lung Cancer Using Deep Learning
|Journal of Magnetic Resonance Imaging|2021|55